The dystrophin-deficient mdx mouse is the most widely used mouse model for DMD as it exhibits much of the pathology observed in patient skeletal muscle, albeit much milder, including elevated creatine kinase levels, increased levels of degeneration and regeneration, fibrosis, and reduced grip strength and whole-body tension [12, 13]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.